Insight

Rafeh Naqash: Important data in the field of toxicities

Photo from Rafeh Naqash/Twitter

Nov 27, 2023, 16:52

Rafeh Naqash: Important data in the field of toxicities

Quoting Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Center, on X/Twitter:

”Hot off the press now in The Lancet Oncology, led by Yu Fujiwara with an excellent team Amin Nassar, Elio Adib, Zain Ul Abideen Asad, Nobuyuki Horita and Susu Zhou. Thank you The Lancet Oncology teams for the editorial support. OU Health Stephenson Cancer Center, Sarah Cannon Docs. Also read commentary!!

Important data in the field of toxicities balancing risk vs benefit and encouraging NEED for multi D care of these individuals getting immunotherapy in the earlier stage setting!”

For the article click here.
Source: Rafeh Naqash/Twitter

Amin Nassar cancer Elio Adib Immune Checkpoint Inhibitors immunotherapy OncoDaily Oncology OU Health Stephenson Cancer Center Rafeh Naqash Sarah Cannon Docs The Lancet Oncology Yu Fujiwara Zain Ul Abideen Asad

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage